Cannabis Users Had Significantly Higher Rates of Heart Rhythm Problems Than Matched Controls

In a matched study of over 420,000 patients, cannabis users had 55% higher risk of atrial fibrillation, 79% higher risk of rapid heart rhythms, and nearly triple the risk of dangerous ventricular arrhythmias compared to ibuprofen users.

Vargas, Juan et al.·Journal of cardiovascular electrophysiology·2025·Strong EvidenceRetrospective Cohort
RTHC-07855Retrospective CohortStrong Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Retrospective Cohort
Evidence
Strong Evidence
Sample
N=1,332

What This Study Found

Cannabis use was associated with significantly increased risk of atrial fibrillation/flutter (HR 1.549), paroxysmal tachycardia (HR 1.791), premature beats (HR 1.739), and ventricular tachycardia/fibrillation (HR 2.839) compared to propensity score-matched ibuprofen users.

Key Numbers

210,817 cannabis users matched with 210,817 ibuprofen users. AF/AFL: HR 1.549 (1,895 vs 1,332 cases). Paroxysmal tachycardia: HR 1.791 (1,065 vs 672). Premature beats: HR 1.739 (1,135 vs 745). VT/VF: HR 2.839 (97 vs 35 cases).

How They Did This

Retrospective cohort study using deidentified electronic health records from 68 U.S. healthcare organizations (TriNetX network). 210,817 cannabis users were matched 1:1 with 210,817 ibuprofen users using propensity score matching across 17 baseline variables. Cox proportional hazards models assessed incident arrhythmia diagnoses.

Why This Research Matters

As cannabis use becomes more common, understanding its cardiovascular risks is essential. This large-scale study provides some of the strongest evidence to date that cannabis use is associated with multiple types of heart rhythm disturbances.

The Bigger Picture

Heart rhythm disturbances can range from benign to life-threatening. The finding that ventricular tachycardia/fibrillation — the most dangerous arrhythmia — showed the strongest association with cannabis use raises important safety questions that need further investigation.

What This Study Doesn't Tell Us

Retrospective observational design cannot prove causation. Ibuprofen users as a comparison group may introduce bias. Cannabis use was identified from health records, which may not capture all users or usage patterns. Confounders may remain despite matching.

Questions This Raises

  • ?What mechanism drives cannabis-associated arrhythmia risk — direct THC effects on ion channels, autonomic nervous system effects, or something else?
  • ?Does dose or frequency matter?
  • ?Are certain cannabis products riskier for heart rhythm?

Trust & Context

Key Stat:
Evidence Grade:
Very large sample with propensity score matching across 17 variables, though retrospective observational design has inherent limitations.
Study Age:
Published 2025.
Original Title:
Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis.
Published In:
Journal of cardiovascular electrophysiology, 36(12), 3261-3267 (2025)
Database ID:
RTHC-07855

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Looks back at existing records to find patterns.

What do these levels mean? →

Frequently Asked Questions

Should people with heart conditions avoid cannabis?

This study suggests cannabis users face elevated arrhythmia risk. People with existing heart rhythm conditions should discuss cannabis use with their cardiologist, as the risk of dangerous ventricular arrhythmias was nearly triple that of controls.

Why were cannabis users compared to ibuprofen users?

Ibuprofen users served as an active comparator group to reduce healthy-user bias. Both groups sought healthcare for a reason, making them more comparable than cannabis users vs. the general population.

Read More on RethinkTHC

Cite This Study

RTHC-07855·https://rethinkthc.com/research/RTHC-07855

APA

Vargas, Juan; Pillai, Keerthana Jyotheeswara; Tocquica-Gahona, Christian; Mahajan, Pranav; Chandna, Sanya; Vyas, Vrinda; Paulraj, Shweta; Yadav, Ritu; Nagarakanti, Rangadham; Raj, Kavin. (2025). Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis.. Journal of cardiovascular electrophysiology, 36(12), 3261-3267. https://doi.org/10.1111/jce.70135

MLA

Vargas, Juan, et al. "Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis.." Journal of cardiovascular electrophysiology, 2025. https://doi.org/10.1111/jce.70135

RethinkTHC

RethinkTHC Research Database. "Cannabis Use and the Risk of Arrhythmias: Insights From a La..." RTHC-07855. Retrieved from https://rethinkthc.com/research/vargas-2025-cannabis-use-and-the

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.